Yiyang Zhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yiyang Zhan has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
Jian Jia
Department of General Practice, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
9 shared publicationsChen Men
Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, China
4 shared publicationsXiaoman Ye
Department of Geriatric Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
4 shared publications- Chong Shen
Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China
3 shared publications Haixia Ding
Department of Health Insurance Management, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China
3 shared publications- Haixia Ding
School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, China
3 shared publications
Latest Publications
- Open Access
- 6 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Prognostic value of point-of-care testing for cardiac myosin-binding protein C in early risk assessment of acute myocardial infarction: a prospective cohort study
The prognostic value of myocardial myosin-binding protein C (cMyC) in acute myocardial infarction (AMI) remains insufficiently studied. To evaluate the association between admission cMyC levels and the risk of 30-day major adverse cardiovascular events (MACE) in patients with AMI. In this prospective, single-center study, patients with AMI admitted between March 2022 and July 2024 were included. cMyC and hs-cTnI were measured by point-of-care testing (POCT) at admission. The primary endpoint was 30-day MACE. Predictive performance was evaluated using ROC analysis and multivariable Cox regression. A total of 285 patients were included, with a 30-day MACE incidence of 27.4%. Admission cMyC was independently associated with 30-day MACE after adjustment for clinical covariates. Exploratory analyses suggested a graded association between cMyC levels and the risk of adverse outcomes. Admission cMyC measured by POCT was independently associated with 30-day MACE in patients with AMI. cMyC may serve as a rapid adjunctive biomarker for early risk stratification, although its incremental predictive value requires further validation.
- 6 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessPrognostic value of point-of-care testing for cardiac myosin-binding protein C in early risk assessment of acute myocardial infarction: a prospective cohort study
The prognostic value of myocardial myosin-binding protein C (cMyC) in acute myocardial infarction (AMI) remains insufficiently studied. To evaluate the association between admission cMyC levels and the risk of 30-day major adverse cardiovascular events (MACE) in patients with AMI. In this prospective, single-center study, patients with AMI admitted between March 2022 and July 2024 were included. cMyC and hs-cTnI were measured by point-of-care testing (POCT) at admission. The primary endpoint was 30-day MACE. Predictive performance was evaluated using ROC analysis and multivariable Cox regression. A total of 285 patients were included, with a 30-day MACE incidence of 27.4%. Admission cMyC was independently associated with 30-day MACE after adjustment for clinical covariates. Exploratory analyses suggested a graded association between cMyC levels and the risk of adverse outcomes. Admission cMyC measured by POCT was independently associated with 30-day MACE in patients with AMI. cMyC may serve as a rapid adjunctive biomarker for early risk stratification, although its incremental predictive value requires further validation.
- Open Access
- 19 March 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1783262
Development and validation of a prediction model for cardiovascular–kidney–metabolic syndrome progression: a multicenter study
Background: Dysfunction of multiple systems significantly contributes to cardiovascular–kidney–metabolic syndrome (CKM). We aimed to use routine indicators to predict progression to CKM and to examine the influence of the liver metabolic axis on CKM progression. Methods: This study was a multicenter retrospective study. We developed a model using new lipid-metabolism indicators to predict progression to CKM. Model performance was evaluated using discrimination, calibration, and decision curve analysis (DCA). Further studies on patients with diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD) explored the link to CKM progression. Results: A total of 21,026 participants with CKM stages 1 or 2 at baseline. The model demonstrated robust discrimination, with AUCs of 0.718 (95% CI 0.704–0.730) in the 2016–2019 cohort, 0.727 (95% CI 0.714–0.740) in the 2020 cohort, and 0.747 (95% CI 0.711–0.777) in the 2021 validation cohort. The predicted-risk quartiles were 1.8, 7.6, 11.4, and 24.9%, respectively. Subgroup analyses confirmed stable discrimination across clinical subgroups and different centers. Exploratory analyses revealed that individuals with diabetes and MASLD had the highest risk of CKM progression (odds ratio [OR] 2.13, 95% CI 1.89–2.40). Conclusion: We developed a reliable model that identifies individuals at risk of progressing to CKM in the real world. Our results also suggest the liver metabolism axis may be crucial in CKM deterioration.
- 19 March 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1783262
Open AccessDevelopment and validation of a prediction model for cardiovascular–kidney–metabolic syndrome progression: a multicenter study
Background: Dysfunction of multiple systems significantly contributes to cardiovascular–kidney–metabolic syndrome (CKM). We aimed to use routine indicators to predict progression to CKM and to examine the influence of the liver metabolic axis on CKM progression. Methods: This study was a multicenter retrospective study. We developed a model using new lipid-metabolism indicators to predict progression to CKM. Model performance was evaluated using discrimination, calibration, and decision curve analysis (DCA). Further studies on patients with diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD) explored the link to CKM progression. Results: A total of 21,026 participants with CKM stages 1 or 2 at baseline. The model demonstrated robust discrimination, with AUCs of 0.718 (95% CI 0.704–0.730) in the 2016–2019 cohort, 0.727 (95% CI 0.714–0.740) in the 2020 cohort, and 0.747 (95% CI 0.711–0.777) in the 2021 validation cohort. The predicted-risk quartiles were 1.8, 7.6, 11.4, and 24.9%, respectively. Subgroup analyses confirmed stable discrimination across clinical subgroups and different centers. Exploratory analyses revealed that individuals with diabetes and MASLD had the highest risk of CKM progression (odds ratio [OR] 2.13, 95% CI 1.89–2.40). Conclusion: We developed a reliable model that identifies individuals at risk of progressing to CKM in the real world. Our results also suggest the liver metabolism axis may be crucial in CKM deterioration.
- Open Access
- 31 May 2024
- Published by EDP Sciences in BIO Web of Conferences
- Vol. 111, 03019
The application of novel digital intelligent device in the assessment of cardiac function in patients with arrhythmia
Acoustic electrocardiography (ACG) is a new non-invasive test that combines the visualization of traditional ECG waveforms and heart-generated sound waveforms to jointly assess cardiac function and cardiac pathology. However, traditional ACG equipment is limited by technology and suffers from problems such as inconvenience and inaccuracy. In recent years, with the development of artificial intelligence technology, some newly developed wearable single-lead ACG devices have appeared, which have applications in the fields of heart failure and coronary heart disease. In order to further clarify the efficacy of this new ACG device for cardiac function assessment in irregular ECG and heart sound waveforms, this study will be validated in patients with arrhythmia, ROC curves show better evaluation of EMAT and EMAT% for HFrEF.
- 31 May 2024
- Published by EDP Sciences in BIO Web of Conferences
- Vol. 111, 03019
Open AccessThe application of novel digital intelligent device in the assessment of cardiac function in patients with arrhythmia
Acoustic electrocardiography (ACG) is a new non-invasive test that combines the visualization of traditional ECG waveforms and heart-generated sound waveforms to jointly assess cardiac function and cardiac pathology. However, traditional ACG equipment is limited by technology and suffers from problems such as inconvenience and inaccuracy. In recent years, with the development of artificial intelligence technology, some newly developed wearable single-lead ACG devices have appeared, which have applications in the fields of heart failure and coronary heart disease. In order to further clarify the efficacy of this new ACG device for cardiac function assessment in irregular ECG and heart sound waveforms, this study will be validated in patients with arrhythmia, ROC curves show better evaluation of EMAT and EMAT% for HFrEF.
- Open Access
- 15 May 2024
- Published by Spandidos Publications in Oncology Letters
- Vol. 28 (1) , 1-9
Predictive model for totally implanted venous access ports‑related long‑term complications in patients with lung cancer
Totally implanted venous access ports (TIVAPs), which are typically used in oncological chemotherapy and parenteral nutritional support, are convenient and safe, and thus offer patients a higher quality of life. However, insertion or removal of the device requires a minor surgical operation. Long‑term complications (>30 days post insertion), such as catheter migration, catheter‑related thrombosis and infection, are major reasons for TIVAP removal and are associated with a number of factors such as body mass index and hemoglobin count. Since management of complications is typically time‑consuming and costly, a predictive model of such events may be of great value. Therefore, in the present study, a predictive model for long‑term complications following TIVAP implantation in patients with lung cancer was developed. After excluding patients with a large amount of missing data, 902 patients admitted to The First Affiliated Hospital with Nanjing Medical University (Nanjing, China) were ultimately included in the present study. Of the included patients, 28 had complications, indicating an incidence rate of 3.1%. Patients were randomly divided into training and test cohorts (7:3), and three machine learning‑based anomaly detection algorithms, namely, the Isolation Forest, one‑class Support Vector Machines (one‑class SVM) and Local Outlier Factor, were used to construct a model. The performance of the model was initially evaluated by the Matthew's correlation coefficient (MCC), area under curve (AUC) and accuracy. The one‑class SVM model demonstrated the highest performance in classifying the risk of complications associated with the use of the intracavitary electrocardiogram method for TIVAP implantation in patients with lung cancer (MCC, 0.078; AUC, 0.62; accuracy, 66.0%). In conclusion, the predictive model developed in the present study may be used to improve the early detection of TIVAP‑related complications in patients with lung cancer, which could lead to the conservation of medical resources and the promotion of medical advances.
- 15 May 2024
- Published by Spandidos Publications in Oncology Letters
- Vol. 28 (1) , 1-9
Open AccessPredictive model for totally implanted venous access ports‑related long‑term complications in patients with lung cancer
Totally implanted venous access ports (TIVAPs), which are typically used in oncological chemotherapy and parenteral nutritional support, are convenient and safe, and thus offer patients a higher quality of life. However, insertion or removal of the device requires a minor surgical operation. Long‑term complications (>30 days post insertion), such as catheter migration, catheter‑related thrombosis and infection, are major reasons for TIVAP removal and are associated with a number of factors such as body mass index and hemoglobin count. Since management of complications is typically time‑consuming and costly, a predictive model of such events may be of great value. Therefore, in the present study, a predictive model for long‑term complications following TIVAP implantation in patients with lung cancer was developed. After excluding patients with a large amount of missing data, 902 patients admitted to The First Affiliated Hospital with Nanjing Medical University (Nanjing, China) were ultimately included in the present study. Of the included patients, 28 had complications, indicating an incidence rate of 3.1%. Patients were randomly divided into training and test cohorts (7:3), and three machine learning‑based anomaly detection algorithms, namely, the Isolation Forest, one‑class Support Vector Machines (one‑class SVM) and Local Outlier Factor, were used to construct a model. The performance of the model was initially evaluated by the Matthew's correlation coefficient (MCC), area under curve (AUC) and accuracy. The one‑class SVM model demonstrated the highest performance in classifying the risk of complications associated with the use of the intracavitary electrocardiogram method for TIVAP implantation in patients with lung cancer (MCC, 0.078; AUC, 0.62; accuracy, 66.0%). In conclusion, the predictive model developed in the present study may be used to improve the early detection of TIVAP‑related complications in patients with lung cancer, which could lead to the conservation of medical resources and the promotion of medical advances.
- Open Access
- 21 March 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 131, 26-31
Inactivated COVID-19 vaccine booster dose shortened the viral shedding time of patients infected with the Omicron variant BA.2
- 21 March 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 131, 26-31
Open AccessInactivated COVID-19 vaccine booster dose shortened the viral shedding time of patients infected with the Omicron variant BA.2
- Open Access
- 1 March 2023
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 16, 1619-1628
Characteristics and Occurrence Scenarios of Staff Exposed to SARS-CoV-2 Omicron in Shanghai Lingang Fangcang Shelter Hospital, CHINA
Objective: To analyze the characteristics and occurrence scenarios of occupational exposure of staff in the Shanghai Lingang Fangcang Shelter Hospital. Methods: We collected the data of 80 staff with occupational exposure (including doctors, nurses, cleaning, security guards, and maintenance staff) in the Shanghai Lingang Fangcang Shelter Hospital from April 5 to May 20, 2022. The basic information of occupational exposure, factors influencing different occupational exposure types, ways to discover occupational exposure, discovery places of occupational exposure, and specific occurrence scenarios were compiled and analyzed among these data. Results: Occupational exposure mainly occurred in nurses (37, 46.25%), and cleaning (21, 26.25%). After the occurrence of occupational exposure, 20 staff (25%) did not know the occurrence time. Moreover, occupational exposure types were listed from high to low proportion as follows: broken protective clothing (56, 70%), mask loosening or displacement (13, 16.25%), skin exposure (6, 7.5%), and sharp object injuries (5, 6.25%). Occupational exposure was discovered mainly through self-discovery (56, 70%), while other discovery ways were majorly colleague discovery (12, 15%) and infection control supervisor discovery (12, 15%). Furthermore, occupational exposure was discovered principally in the public area (53.75%) and the office area (25%) of the cabin, but the proportion of mask loosening or displacement (38.46%) and skin exposure (50%) was also high in the first unloading area. Broken protective clothing occurred in the following scenarios: scratching while working in the cabin (37, 66.07%) and not knowing its occurrence time (25%). The occurrence scenarios of mask loosening or displacement were mainly not knowing its occurrence time (6, 46.15%), self-discovery (3, 23.08%), and at the time of removal (3, 23.08%). Conclusion: Targeted training and prevention of occupational exposure should be performed to decrease infection risk and ensure staff safety in Fangcang shelter hospitals.
- 1 March 2023
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 16, 1619-1628
Open AccessCharacteristics and Occurrence Scenarios of Staff Exposed to SARS-CoV-2 Omicron in Shanghai Lingang Fangcang Shelter Hospital, CHINA
Objective: To analyze the characteristics and occurrence scenarios of occupational exposure of staff in the Shanghai Lingang Fangcang Shelter Hospital. Methods: We collected the data of 80 staff with occupational exposure (including doctors, nurses, cleaning, security guards, and maintenance staff) in the Shanghai Lingang Fangcang Shelter Hospital from April 5 to May 20, 2022. The basic information of occupational exposure, factors influencing different occupational exposure types, ways to discover occupational exposure, discovery places of occupational exposure, and specific occurrence scenarios were compiled and analyzed among these data. Results: Occupational exposure mainly occurred in nurses (37, 46.25%), and cleaning (21, 26.25%). After the occurrence of occupational exposure, 20 staff (25%) did not know the occurrence time. Moreover, occupational exposure types were listed from high to low proportion as follows: broken protective clothing (56, 70%), mask loosening or displacement (13, 16.25%), skin exposure (6, 7.5%), and sharp object injuries (5, 6.25%). Occupational exposure was discovered mainly through self-discovery (56, 70%), while other discovery ways were majorly colleague discovery (12, 15%) and infection control supervisor discovery (12, 15%). Furthermore, occupational exposure was discovered principally in the public area (53.75%) and the office area (25%) of the cabin, but the proportion of mask loosening or displacement (38.46%) and skin exposure (50%) was also high in the first unloading area. Broken protective clothing occurred in the following scenarios: scratching while working in the cabin (37, 66.07%) and not knowing its occurrence time (25%). The occurrence scenarios of mask loosening or displacement were mainly not knowing its occurrence time (6, 46.15%), self-discovery (3, 23.08%), and at the time of removal (3, 23.08%). Conclusion: Targeted training and prevention of occupational exposure should be performed to decrease infection risk and ensure staff safety in Fangcang shelter hospitals.
- Open Access
- 1 January 2023
- Published by Discovery Medicine in Discovery Medicine
- Vol. 35 (179) , 1114-1122
Construction of a Nomogram Model to Identify Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
Background: Approximately 50.0% of patients with type 2 diabetes mellitus (T2DM) experience macrovascular diseases, and nearly 80.0% of them succumb to macrovascular complications. Atherosclerotic cardiovascular disease (ASCVD) ranks among the most prevalent macrovascular complications in T2DM. In this study, we aim to develop a nomogram model for the early detection of ASCVD in T2DM patients, enabling us to provide valuable recommendations for the clinical prevention and management of macrovascular complications in this patient population. Methods: This retrospective analysis encompassed 2620 T2DM patients admitted between June 2015 and June 2021. The cohort comprised 1270 T2DM patients with coexisting ASCVD (referred to as the “ASCVD group") and 1350 individuals who did not experience ASCVD (the “non-ASCVD group"). We conducted a comparative assessment of their baseline characteristics and clinical data. A nomogram model for the identification of ASCVD in T2DM patients was constructed utilizing Logistic regression analysis and the R package. The model's performance was evaluated through receiver operating characteristic (ROC) curve analysis and calibration curves. Results: We developed a nomogram model for the identification of ASCVD in T2DM patients, incorporating ten variables: sex, age, hypertension, smoking history, low-density lipoprotein cholesterol/high-density lipoprotein cholesterol (LDL-C/HDL-C) ratio, alanine transaminase (ALT), adenosine deaminase (ADA), postprandial 2-hour C-peptide, monocyte count (MONO), and eosinophil count (EOS). ROC curves demonstrated that the area under the curve (AUC) of the nomogram model for identifying ASCVD in T2DM patients was 0.673 for the training dataset (with a cut-off value of 0.473, specificity of 0.629, and sensitivity of 0.637) and 0.655 for the validation dataset (with a cut-off value of 0.460, specificity of 0.605, and sensitivity of 0.675). The calibration curve indicated a substantial agreement between the predicted and observed cases of ASCVD in the training dataset and an acceptable level of agreement in the validation dataset. Conclusions: The nomogram model effectively identifies ASCVD in T2DM patients, which can be instrumental in pinpointing the high-risk population for ASCVD among T2DM patients and facilitating timely clinical management.
- 1 January 2023
- Published by Discovery Medicine in Discovery Medicine
- Vol. 35 (179) , 1114-1122
Open AccessConstruction of a Nomogram Model to Identify Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
Background: Approximately 50.0% of patients with type 2 diabetes mellitus (T2DM) experience macrovascular diseases, and nearly 80.0% of them succumb to macrovascular complications. Atherosclerotic cardiovascular disease (ASCVD) ranks among the most prevalent macrovascular complications in T2DM. In this study, we aim to develop a nomogram model for the early detection of ASCVD in T2DM patients, enabling us to provide valuable recommendations for the clinical prevention and management of macrovascular complications in this patient population. Methods: This retrospective analysis encompassed 2620 T2DM patients admitted between June 2015 and June 2021. The cohort comprised 1270 T2DM patients with coexisting ASCVD (referred to as the “ASCVD group") and 1350 individuals who did not experience ASCVD (the “non-ASCVD group"). We conducted a comparative assessment of their baseline characteristics and clinical data. A nomogram model for the identification of ASCVD in T2DM patients was constructed utilizing Logistic regression analysis and the R package. The model's performance was evaluated through receiver operating characteristic (ROC) curve analysis and calibration curves. Results: We developed a nomogram model for the identification of ASCVD in T2DM patients, incorporating ten variables: sex, age, hypertension, smoking history, low-density lipoprotein cholesterol/high-density lipoprotein cholesterol (LDL-C/HDL-C) ratio, alanine transaminase (ALT), adenosine deaminase (ADA), postprandial 2-hour C-peptide, monocyte count (MONO), and eosinophil count (EOS). ROC curves demonstrated that the area under the curve (AUC) of the nomogram model for identifying ASCVD in T2DM patients was 0.673 for the training dataset (with a cut-off value of 0.473, specificity of 0.629, and sensitivity of 0.637) and 0.655 for the validation dataset (with a cut-off value of 0.460, specificity of 0.605, and sensitivity of 0.675). The calibration curve indicated a substantial agreement between the predicted and observed cases of ASCVD in the training dataset and an acceptable level of agreement in the validation dataset. Conclusions: The nomogram model effectively identifies ASCVD in T2DM patients, which can be instrumental in pinpointing the high-risk population for ASCVD among T2DM patients and facilitating timely clinical management.
- Open Access
- 1 March 2022
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 23 (4) , 1-8
Vitamin D receptor deficiency increases systolic blood pressure by upregulating the renin‑angiotensin system and autophagy
The vitamin D receptor (VDR) may regulate blood pressure via multiple pathways. The present study investigated the underlying mechanism by which VDR deficiency increases blood pressure. A total of 16 8‑week‑old male littermate mice were randomly divided into the VDR knockout and wild‑type groups (VDR‑/‑ and VDR+/+, respectively). Blood pressure was measured using a four‑channel PowerLab data acquisition and ADI software analysis system. After euthanasia, vascular smooth muscle cells (VSMCs) were isolated from the VDR‑/‑ and VDR+/+ mice. Oxidative stress, renin‑angiotensin system (RAS) activation and autophagy markers were measured in the isolated VSMCs using reverse transcription‑quantitative PCR (RT‑qPCR), western blotting and transmission electron microscopy (TEM) assays. Mean systolic pressure was significantly higher in the VDR‑/‑ mice compared with the VDR+/+ mice. RT‑qPCR and western blotting analyses indicated that RAS markers (angiotensin II and II type 1 receptor) were significantly upregulated, oxidative stress was increased (evidenced by reduced superoxide dismutase and peroxiredoxin‑4) and autophagy was activated (upregulation of autophagy related protein 7, Beclin 1 and microtubule‑associated proteins 1A/1B light chain 3A) in the VDR‑/‑ VSMCs compared with the VDR+/+ VSMCs. TEM demonstrated that there were more autophagy bodies in the VDR‑/‑ VSMCs compared with the VDR+/+ VSMCs. In conclusion, VDR deficiency was associated with high blood pressure. The mechanism underlying the increase in blood pressure caused by VDR deficiency may involve activation of the RAS, as well as increased oxidative stress and autophagy of VSMCs.
- 1 March 2022
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 23 (4) , 1-8
Open AccessVitamin D receptor deficiency increases systolic blood pressure by upregulating the renin‑angiotensin system and autophagy
The vitamin D receptor (VDR) may regulate blood pressure via multiple pathways. The present study investigated the underlying mechanism by which VDR deficiency increases blood pressure. A total of 16 8‑week‑old male littermate mice were randomly divided into the VDR knockout and wild‑type groups (VDR‑/‑ and VDR+/+, respectively). Blood pressure was measured using a four‑channel PowerLab data acquisition and ADI software analysis system. After euthanasia, vascular smooth muscle cells (VSMCs) were isolated from the VDR‑/‑ and VDR+/+ mice. Oxidative stress, renin‑angiotensin system (RAS) activation and autophagy markers were measured in the isolated VSMCs using reverse transcription‑quantitative PCR (RT‑qPCR), western blotting and transmission electron microscopy (TEM) assays. Mean systolic pressure was significantly higher in the VDR‑/‑ mice compared with the VDR+/+ mice. RT‑qPCR and western blotting analyses indicated that RAS markers (angiotensin II and II type 1 receptor) were significantly upregulated, oxidative stress was increased (evidenced by reduced superoxide dismutase and peroxiredoxin‑4) and autophagy was activated (upregulation of autophagy related protein 7, Beclin 1 and microtubule‑associated proteins 1A/1B light chain 3A) in the VDR‑/‑ VSMCs compared with the VDR+/+ VSMCs. TEM demonstrated that there were more autophagy bodies in the VDR‑/‑ VSMCs compared with the VDR+/+ VSMCs. In conclusion, VDR deficiency was associated with high blood pressure. The mechanism underlying the increase in blood pressure caused by VDR deficiency may involve activation of the RAS, as well as increased oxidative stress and autophagy of VSMCs.
- Open Access
- 1 April 2021
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 9 (8) , 627
Apelin receptor upregulation in spontaneously hypertensive rat contributes to the enhanced vascular smooth muscle cell proliferation by activating autophagy
Background: Proliferation of vascular smooth muscle cells (VSMCs) plays a vital role in the progression of vascular remodeling and hypertension. Apelin-13 promotes VSMC proliferation of normal rats. This study was designed to investigate the roles of apelin receptor (APJ) and apelin-13 in VSMC proliferation of hypertension rats and underlying mechanisms. Methods: Primary VSMCs were obtained from aorta of Wistar-Kyoto rat (WKY) and spontaneously hypertensive rat (SHR). The expressions of apelin and APJ were detected by Western bolt and PCR, as well as immunohistochemistry. VSMC proliferation was evaluated with CCK-8 kit, PCNA protein expression and percentage of EdU-positive cells. Autophagy was determined by the ratio of LC3BII to LC3BI, ATG5 and p62 protein expressions, as well as LC3B immunofluorescence. Results: APJ expression was increased while apelin expression was reduced in aorta and VSMCs of SHR compared with those of WKY. Exogenous apelin-13 promoted VSMC proliferation and autophagy of both WKY and SHR, which were prevented by APJ antagonist F13A. Blockade of APJ had no significant effects on VSMC proliferation and autophagy of WKY, but attenuated VSMC proliferation and autophagy of SHR. Administration of autophagy inhibitor 3-methyladenine (3-MA) not only attenuated VSMC proliferation of SHR, but prevented apelin-13-induced VSMC proliferation of both WKY and SHR. Conclusions: Apelin-13 stimulates VSMC proliferation via APJ-mediated enhancement in autophagy. APJ upregulation in SHR contributes to the enhanced VSMC proliferation.
- 1 April 2021
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 9 (8) , 627
Open AccessApelin receptor upregulation in spontaneously hypertensive rat contributes to the enhanced vascular smooth muscle cell proliferation by activating autophagy
Background: Proliferation of vascular smooth muscle cells (VSMCs) plays a vital role in the progression of vascular remodeling and hypertension. Apelin-13 promotes VSMC proliferation of normal rats. This study was designed to investigate the roles of apelin receptor (APJ) and apelin-13 in VSMC proliferation of hypertension rats and underlying mechanisms. Methods: Primary VSMCs were obtained from aorta of Wistar-Kyoto rat (WKY) and spontaneously hypertensive rat (SHR). The expressions of apelin and APJ were detected by Western bolt and PCR, as well as immunohistochemistry. VSMC proliferation was evaluated with CCK-8 kit, PCNA protein expression and percentage of EdU-positive cells. Autophagy was determined by the ratio of LC3BII to LC3BI, ATG5 and p62 protein expressions, as well as LC3B immunofluorescence. Results: APJ expression was increased while apelin expression was reduced in aorta and VSMCs of SHR compared with those of WKY. Exogenous apelin-13 promoted VSMC proliferation and autophagy of both WKY and SHR, which were prevented by APJ antagonist F13A. Blockade of APJ had no significant effects on VSMC proliferation and autophagy of WKY, but attenuated VSMC proliferation and autophagy of SHR. Administration of autophagy inhibitor 3-methyladenine (3-MA) not only attenuated VSMC proliferation of SHR, but prevented apelin-13-induced VSMC proliferation of both WKY and SHR. Conclusions: Apelin-13 stimulates VSMC proliferation via APJ-mediated enhancement in autophagy. APJ upregulation in SHR contributes to the enhanced VSMC proliferation.
- Open Access
- 20 December 2019
- Published by Wiley in Journal of Diabetes Research
- Vol. 2019, 1-11
Cost-Effectiveness of Bariatric Surgery versus Medication Therapy for Obese Patients with Type 2 Diabetes in China: A Markov Analysis
Aims/Introduction. The present study estimated the cost-effectiveness of bariatric surgery versus medication therapy for the management of recently diagnosed type 2 diabetes mellitus (T2DM) in obese patients from a Chinese health insurance payer perspective. Materials and Methods. A Markov model was established to compare the 40-year time costs and quality-adjusted life-years (QALYs) between bariatric surgery and medication therapy. The health-care costs in the bariatric surgery group, proportion of patients in each group with remission of diabetes, and state transition probabilities were calculated based on observed resource utilization from the hospital information system (HIS). The corresponding costs in the medication therapy group were derived from the medical insurance database. QALYs were estimated from previous literature. Costs and outcomes were discounted 5% annually. Results. In the base case analysis, bariatric surgery was more effective and less costly than medication therapy. Over a 40-year time horizon, the mean discounted costs were 86,366.55 RMB per surgical therapy patient and 113,235.94 CNY per medication therapy patient. The surgical and medication therapy patients lived 13.46 and 10.95 discounted QALYs, respectively. Bariatric surgery was associated with a mean health-care savings of 26,869.39 CNY and 2.51 additional QALYs per patient compared to medication therapy. Uncertainty around the parameter values was tested comprehensively in sensitivity analyses, and the results were robust. Conclusions. Bariatric surgery is a dominant intervention over a 40-year time horizon, which leads to significant cost savings to the health insurance payer and increases in health benefits for the management of recently diagnosed T2DM in obese patients in China.
- 20 December 2019
- Published by Wiley in Journal of Diabetes Research
- Vol. 2019, 1-11
Open AccessCost-Effectiveness of Bariatric Surgery versus Medication Therapy for Obese Patients with Type 2 Diabetes in China: A Markov Analysis
Aims/Introduction. The present study estimated the cost-effectiveness of bariatric surgery versus medication therapy for the management of recently diagnosed type 2 diabetes mellitus (T2DM) in obese patients from a Chinese health insurance payer perspective. Materials and Methods. A Markov model was established to compare the 40-year time costs and quality-adjusted life-years (QALYs) between bariatric surgery and medication therapy. The health-care costs in the bariatric surgery group, proportion of patients in each group with remission of diabetes, and state transition probabilities were calculated based on observed resource utilization from the hospital information system (HIS). The corresponding costs in the medication therapy group were derived from the medical insurance database. QALYs were estimated from previous literature. Costs and outcomes were discounted 5% annually. Results. In the base case analysis, bariatric surgery was more effective and less costly than medication therapy. Over a 40-year time horizon, the mean discounted costs were 86,366.55 RMB per surgical therapy patient and 113,235.94 CNY per medication therapy patient. The surgical and medication therapy patients lived 13.46 and 10.95 discounted QALYs, respectively. Bariatric surgery was associated with a mean health-care savings of 26,869.39 CNY and 2.51 additional QALYs per patient compared to medication therapy. Uncertainty around the parameter values was tested comprehensively in sensitivity analyses, and the results were robust. Conclusions. Bariatric surgery is a dominant intervention over a 40-year time horizon, which leads to significant cost savings to the health insurance payer and increases in health benefits for the management of recently diagnosed T2DM in obese patients in China.